Karen Pendergrass, Standards Team

About

Karen Pendergrass is a microbiome researcher specializing in microbiome-targeted interventions (MBTIs). She systematically analyzes scientific literature to identify microbial patterns, develop hypotheses, and validate interventions. As the founder of the Microbiome Signatures Database, she bridges microbiome research with clinical practice. In 2012, based on her own investigative research, she became the first documented case of FMT for Celiac Disease—four years before the first published case study.

Recent Posts

2024-01-01 00:00:00

Breast cancer but not the menopausal status is associated with small changes of the gut microbiota

2024-01-01 00:00:00

Gut and oral microbial compositional differences in women with breast cancer, women with ductal carcinoma in situ, and healthy women

2023-01-01 00:00:00

Profiling the oral microbiomes in patients with Alzheimer’s disease

2023-01-01 00:00:00

Integrated Multi-Cohort Analysis of the Parkinson’s Disease Gut Metagenome

2023-01-01 00:00:00

The alteration of intestinal mucosal α-synuclein expression and mucosal microbiota in Parkinson’s disease

2023-01-01 00:00:00

The link between increased Desulfovibrio and disease severity in Parkinson’s disease

2023-01-01 00:00:00

Differences in the gut microbiome across typical ageing and in Parkinson’s disease

2023-01-01 00:00:00

Dysbiosis of gut microbiota inhibits NMNAT2 to promote neurobehavioral deficits and oxidative stress response in the 6-OHDA-lesioned rat model of Parkinson’s disease

2023-01-01 00:00:00

Gut microbiota-associated taurine metabolism dysregulation in a mouse model of Parkinson’s disease

2023-01-01 00:00:00

Dysbiosis of the Beneficial Gut Bacteria in Patients with Parkinson’s Disease from India

← Prev 1 …30 31 32 33 34 …47 Next →